written on 26.03.2014
Tags:
,

AstraZeneca takes control of its destiny in Japan with buyout

TAGS: ,

Japan is the second largest drug market after the U.S., and Western drugmakers are giving it new attention as growth slows elsewhere. AstraZeneca has upped its bet there, paying Sumitomo Chemical about $102 million to buy full control of its Japanese subsidiary AstraZeneca KK.

Latest Report